CDH1 and breast cancer: In HBC, E-cadherin is known to be an inhibitor of metastasis, and its downregulation or inactivation leads to aggressive forms of breast cancer, EMT, lymphovascular invasion and metastasis (246, 247), as well as higher histological grade (248).